Explore 3 Stock Ideas & Industry Insights Download Free Report

News

State Street Discloses 5.1% Stake in SM Energy

State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 12,089,494 shares of SM Energy Co common stock, representing 5.1% of the class, as of September 30, 2026.

Nitish Kishor | 10 November 2026

State Street Discloses 5.1% Stake in SELLAS Life Sciences

State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing a beneficial ownership position in SELLAS Life Sciences Group Inc as of September 30, 2026.

Nitish Kishor | 10 November 2026

State Street Discloses 11.87M Shares in T1 Energy

State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 11,869,473 shares of common stock in T1 Energy Inc. as of September 30, 2026.

Anjali Anand | 10 November 2026

State Street Discloses 6.6% Stake in SunCoke Energy

State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, reporting beneficial ownership of 5,636,632 shares of SunCoke Energy Inc. common stock as of September 30, 2026.

Nitish Kishor | 10 November 2026

MIND CTI Signs Merger Agreement With Enghouse Systems

MIND C.T.I. Ltd. filed a Form 6-K on November 10, 2026, disclosing that it entered into an Agreement and Plan of Merger with Enghouse Holdings (UK) Limited, a wholly owned subsidiary of Enghouse Systems Limited (TSX:ENGH), on that same date.

Aakashdeep | 10 November 2026

Morgan Stanley MSFL Basket-Linked Notes Due May 2029

Morgan Stanley Finance LLC filed a free writing prospectus on November 10, 2026, for Preliminary Pricing Supplement No. 20,014, covering principal-at-risk securities linked to an unequally weighted basket of five international equity indices, with a stated maturity of May 17, 2029.

Aakashdeep | 10 November 2026

State Street Reports 5.2% Stake in Syndax Pharmaceuticals

State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing a beneficial ownership position in Syndax Pharmaceuticals Inc. as of September 30, 2026.

Aditi Sarkar | 10 November 2026

State Street Reports 5% Stake in TKO Group Holdings

State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of approximately 5% of TKO Group Holdings Inc common stock as of September 30, 2026.

Nitish Kishor | 10 November 2026

State Street Reports 5.1% Stake in Tapestry Inc

State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing a 5.1% beneficial ownership position in Tapestry Inc as of September 30, 2026.

Aakashdeep | 10 November 2026

Flowco CEO Edwards Buys 20,000 Shares at $19.49

Joseph R. Edwards, President and CEO of Flowco Holdings Inc., filed a Form 4 on November 10, 2026, disclosing an open-market purchase of Class A Common Stock on November 5, 2026.

Anjali Anand | 10 November 2026
Support

Hi! How can we help you today?

Loading…